Glenmark receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

According to IQVIA sales data for the 12-month period ending August, the Tecfidera Delayed-Release Capsules, 120 mg and 240 mg market2 achieved annual sales of approximately $3.8 billion*.

from India Infoline News Service https://ift.tt/34vMziL